ArticleFrontiers in neurology2019
Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature.
Article in Frontiers in neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review.Journal of neurology · 2024Pooled it
- Anti-IgLON5 disease presenting with a motor neuron disease-like phenotype after decades of sleep symptoms: a potentially immunotherapy responsive mimic.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Article
- The Intersection of Autoimmunity and Sleep: Anti-IgLON5 as the Key Player in a Case Series.Cureus · 2026Article
- Anti-IgLON5 encephalitis is associated with anti-retinal immunological reactivity without retinal alteration.Journal of translational autoimmunity · 2026Article
- A patient with anti-IgLON5 disease associated with cerebral hemorrhage, multiple ischemic strokes, and kidney failure: case report.Journal of neurology · 2026Article
- Causes of Death in Anti-IgLON5 Disease: A Novel Case Report and Systematic Literature Review.Brain sciences · 2025Article
- The Expanding Spectrum of Anti-IgLON5 Disease: A Case Series from an Indian Cohort.Annals of Indian Academy of Neurology · 2025Article
- Sleep Disturbances in Autoimmune Neurological Diseases: Mechanisms, Clinical Characteristics, Assessment, and Treatment Strategies.Current neurology and neuroscience reports · 2024Review
- Further insights into anti-IgLON5 disease: a case with complex clinical presentation.BMC neurology · 2024Article
- Anti-IgLON5 Disease Showing an Improvement in Dysautonomia, Including Vocal Cord Palsy, via Combined Immunotherapy.Internal medicine (Tokyo, Japan) · 2024Article
- Diagnosis and Management of Progressive Corticobasal Syndrome.Current treatment options in neurology · 2024Article
- Coexistence of anti-NMDAR and anti-IgLON5 antibodies in an autoimmune encephalitis patient: The first case report.Heliyon · 2024Article
- HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 disease.Frontiers in immunology · 2024Article
- The psychiatric symptoms in anti-IgLON5 disease: Case report and literature review.Clinical case reports · 2024Article
- Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease.Acta neuropathologica · 2023Article
- Review
- Sleep disorders and polysomnography findings in patients with autoimmune encephalitis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023Article
- Thinking beyond otorhinolaryngology in patients presenting with bilateral vocal cord paresis.Journal of surgical case reports · 2023Article
- Anti-IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature.Movement disorders clinical practice · 2023Review
- Sleep disturbances in autoimmune encephalitis.Encephalitis (Seoul, Korea) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.